|本期目录/Table of Contents|

[1]朱皓皞,于晓红,杜丽英,等.宫颈癌中激活蛋白1通路的活化及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):128-131.[doi:10.3969/j.issn.1672-271X.2014.02.005]
　ZHU Hao-hao,YU Xiao-hong,DU Li-ying,et al.Clinical significance of AP-1 pathway alterations in cervical carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(02):128-131.[doi:10.3969/j.issn.1672-271X.2014.02.005]
点击复制

宫颈癌中激活蛋白1通路的活化及临床意义()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第16卷
期数:
2014年02期
页码:
128-131
栏目:
出版日期:
2014-03-20

文章信息/Info

Title:
Clinical significance of AP-1 pathway alterations in cervical carcinoma
作者:
朱皓皞1; 于晓红2; 杜丽英1; 熊敦勇1; 寇 辉1; 王芳胜1
1.330002 江西南昌，解放军94医院病理科；2.330006 江西南昌，江西省妇幼保健院病理科
Author(s):
ZHU Hao-hao1; YU Xiao-hong2; DU Li-ying1; XIONG Dun-yong1; KOU Hui1; WANG Fang-sheng1.
1.Department of　Pathology，94 Hospital of PLA，Nanchang,Jiangxi 330002，China；2.Department of Pathology，Jiangxi Maternal and Child Health Hospital，Nanchang，Jiangxi 330006，China
关键词:
宫颈癌; 激活蛋白1; 免疫组化; 病理学
Keywords:
cervical carcinoma; activator protein-1; immunohistochemistry; pathology
分类号:
R737.33
DOI:
10.3969/j.issn.1672-271X.2014.02.005
文献标志码:
A
摘要:
目的 探讨激活蛋白1(AP-1)信号通路的重要组分c-jun和c-fos在宫颈癌中的表达及临床意义。方法 免疫组织化学(SP)法检测c-jun和c-fos在70例宫颈鳞状细胞癌、30例宫颈上皮内瘤变及20例慢性宫颈炎中的表达情况，同时分析其与宫颈癌临床病理特征和预后的关系。结果 70例宫颈癌中c-jun和c-fos的阳性表达率分别为57.1%(40/70)、60.0%(42/70)，在30例宫颈上皮内瘤变的表达阳性率分别为53.3%(16/30)、63.3%(19/30)，而在20例慢性宫颈炎的表达阳性率均为0；宫颈癌组与宫颈炎组相比差异有统计学意义(P＜0.01)，宫颈癌组与宫颈上皮瘤病变组相比差异无统计学意义(P＞0.05)。c-jun和c-fos表达与宫颈癌的临床分期、组织学分级、淋巴结转移等分组中差异具有统计学意义(P<0.05)，但与患者年龄及肿瘤的大小等分组中的表达差异无统计学意义(P>0.05)。c-jun和c-fos在宫颈癌的表达呈正相关(r=0.67，P<0.05)。结论 AP-1信号通路活化可能与宫颈鳞状细胞癌发生发展相关，c-jun和c-fos在致瘤过程中可能起协同作用。
Abstract:
Objective To investigate the expression and clinical significance of activator protein-1 (AP-1),an important signaling pathway component of c-jun and c-fos,in cervical cancer.Methods Immunohistochemical (SP) method was used to detect the expression of c-jun and c-fos in 70 cases of cervical squamous cell carcinoma,30 cases of cervical intraepithelial lesions and 20 cases of chronic cervicitis.The relationship between expressions and clinicopathologic characteristics and prognostic significance was analyzed.Results The positive expression rates of c-jun and c-fos were 57.1% (40/70) and 60% (42/70) in 70 cases of cervical squamous cell carcinoma.The positive expression rates were 53.3% (16/30) and 63.3% (19/30) in 30 cases of cervical intraepithelial neoplasia.The positive expression rate in the 20 cases of chronic cervicitis was 0.The expression rate in cervical cancer group and the chronic cervicitis group has a significant difference (P＜0.01),in cervical cancer and cervical intraepithelial neoplasia group has not statistically significant difference (P>0.05).The different expression of c-jun and c-fos protein in cervical carcinomas was statistically significant in the different groups of clinical stage,pathology grading and lymph node metastasis (P<0.05),but was not statistically significant in the different groups of tumor size and the patient age (P>0.05).Additionally,the expression of c-jun was positively correlated with that of c-fos (r=0.67,P<0.05).Conclusion AP-1 pathway alterations may play a critical role in the development of cervical cancer,and c-jun and c-fos make synergistic action during the process of cervical cancer.

参考文献/References:

[1]Kokawa K，Takekida S，Kamiura S，et al.The incidence，treatment and prognosis of cervical carcionma in young women:a retrospective analysis of 4,975 cases in Japan[J].Eur J Gynaecol Oncol，2010，31(1):37-43.
[2]Poljak M,Otrbenk A.The abbott real time high risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older:a review of validation studies[J].Acta Dermatovenerol Alp Panonica Adriat，2013，22(2):43-47.
[3]Nur S，Chuang L，Ramaswamy G.Immunohistochemical characterization　of　cancer antigen in uterine cancers[J].Int J Gynecol Cancer，2006，16(5):1903-1910.
[4]de Wilde J,De-Castro Arce J,Snijders PJ,et al.Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis[J].Cell Oncol，2008，30(1):77-87.
[5]朱 宁，原继荣，王德莹.c-fos 和c-jun与癌症关系的研究进展[J].中国优生与遗传杂志，2012，20(2):6-7.
[6]Maritz MF,van der Watt PJ,Holderness N,et al.Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression[J].Biol Chem，2011，392(5):439-448.
[7]Juneja M，Ilm K，Schlag PM，et al.Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer[J].Mol Oncol，2013，7(5):929-943.
[8]Lee EJ，Lee SJ，Kim S，et al.Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway:involvement of the p21WAF1 expression[J].Cell Signal，2013，25(10):2025-2038.
[9]Ding X，Pan H，Li J，et al.Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis[J].Sci Signal，2013，6(273):1-13.
[10] Prusty BK，Das BC.Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin[J].Int J Cancer，2005，113(6):951-960.
[11] 熊 晶，刘凤英，陶光实.c-fos 和c-jun在宫颈癌、CIN及宫颈炎中的表达及意义[J].现代生物医学进展，2009，9(4):687-689.
[12] 晋红中，王家璧.c-jun c-fos在尖锐湿疣和宫颈鳞状细胞癌发病中的作用[J].中国皮肤性病学杂志，2001，15(3):159-162.　
[13] Toft DJ，Rosenberg SB，Bergers G，et al.Reactivation of proliferin　gene expression is associated with increased angiogenesis in a cell　culture model of fibrosarcoma tumor progression[J].Proc Nati Acad　Sci USA，2001，98(23):13055-13059.

相似文献/References:

[1]吴 曼,骆文香,崔向华,等.结肠癌宫颈转移1例[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):26.
[2]陶一蕾,邱玲琍,王 冰.早期巨块型宫颈癌术前放化疗的临床研究[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):344.
[3]张 飞,朱湘玉,杨瑞宁.液基涂片细胞学检查联合高危型HPV检测在宫颈病变诊断中的价值[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):28.[doi:10.3969/j.issn.1672-271X.2016.01.008]
　ZHANG Fei,ZHU Xiang-yu,YANG Rui-ning..The value of diagnosing cervical lesions by Thinprep cytologic test (TCT) combined with high-risk type HPV DNA testing[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(02):28.[doi:10.3969/j.issn.1672-271X.2016.01.008]
[4]丁 虹,唐雯静,庞燕芬,等.马齿苋多糖对宫颈癌细胞恶性生物学行为抑制作用的实验研究[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):38.[doi:10.3969/j.issn.1672-271X.2016.01.011]
　DING Hong,TANG Wen-jing,PANG Yan-fen,et al.Animal study on the inhibition effect of Portulaca oleracea polysaccharide on malignant behavior of cervical cancer cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(02):38.[doi:10.3969/j.issn.1672-271X.2016.01.011]
[5]雷月,朱烨,李娟,等.MRI联合鳞状细胞癌抗原在宫颈鳞状细胞癌淋巴结转移的诊断价值[J].医学研究与战创伤救治(原医学研究生学报),2019,21(5):524.[doi:10.3969/j.issn.1672-271X.2019.05.017]
[6]范佳杨,梁婷,刘康,等.糖酵解关键酶在宫颈癌Warburg效应中的作用研究进展[J].医学研究与战创伤救治(原医学研究生学报),2021,23(02):175.[doi:10.3969/j.issn.1672-271X.2021.02.014]
　FAN Jia-yang,LIANG Ting,LIU Kang,et al.Research progression of the infection of glycolytic enzymein the Warburg effect in cervical cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(02):175.[doi:10.3969/j.issn.1672-271X.2021.02.014]
[7]胡丽花,赵嫦娥,宋成文.增敏化疗对宫颈癌同步放疗患者生存质量和免疫功能的影响研究[J].医学研究与战创伤救治(原医学研究生学报),2021,23(6):588.[doi:10.3969/j.issn.1672-271X.2021.06.006]
　HU Li-hua,ZHAO Chang-e,SONG Cheng-wen.Study on the effect of sensitization chemotherapy on the quality of life and immune function of patients with cervical cancer receiving concurrent radiotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(02):588.[doi:10.3969/j.issn.1672-271X.2021.06.006]
[8]王霁,唐媛媛,华羽晨,等.便携式膀胱扫描仪在宫颈癌患者CT模拟定位及调强放疗中的精准应用[J].医学研究与战创伤救治(原医学研究生学报),2022,24(1):83.[doi:10.3969/j.issn.1672-271X.2022.01.019]

备注/Memo

备注/Memo:
南京军区医学科技创新课题(12MB022)
更新日期/Last Update: 2014-03-20